MAPT and amyloidosis: Likewise, the concept of suspected non-Alzheimer’s pathophysiology (SNAP) highlights individuals with neurodegeneration biomarkers (cerebrospinal fluid tau, MTL atrophy, and decreased metabolism in AD-like patterns) in the absence of amyloid plaque burden [70].